Try our Advanced Search for more refined results
April 07, 2014
IN RE ACTOS END PAYOR ANTITRUST LITIGATION
Case Number:
1:14-cv-02424
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
- Allergan PLC
- Ranbaxy
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 09, 2014
Workers Fund Says Takeda, Generics Delayed Diabetes Drug
Takeda Pharmaceutical Co. Ltd., Mylan Inc. and others were hit Monday in New York federal court with a proposed antitrust class action by an electrical workers benefit fund that says the companies unlawfully delayed generic competition for diabetes drugs Actos and Actoplus Met.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login